Skip to main content
. Author manuscript; available in PMC: 2010 Dec 22.
Published in final edited form as: Circulation. 2009 Nov 17;120(25):2529–2540. doi: 10.1161/CIRCULATIONAHA.109.913111

Table 3.

Hazard Ratio (HR) of Rev/IMT for MI, Cardiac Death, and Cardiac Death or MI within Glycemic Randomization Arm

MI
Cardiac Death
Cardiac Death/MI
5 Year KM Estimate HR Rev/IMT (95% CI) Nominal p-value for HR 5 Year KM Estimate HR Rev/IMT (95% CI) Nominal p-value for HR 5 Year KM Estimate HR Rev/IMT (95% CI) Nominal p-value for HR
All Patients (n = 2368)
Insulin Sensitization
Rev(n= 584) 10.3% (56) 0.78 (0.55–1.10) 0.16 5.5% (34) 1.11 (0.68–1.80) 0.68 14.2% (79) 0.92 (0.68–1.24) 0.57
IMT(n=599) 14.1% (74) 5.8% (32) 16.9% (89)
Insulin Provision
Rev(n= 592) 12.7% (72) 0.97 (0.70–1.34) 0.85 6.4% (38) 1.21 (0.76–1.94) 0.42 17.6% (99) 1.15 (0.86–1.52) 0.35
IMT(n=593) 14.4% (77) 5.7% (32) 16.5% (90)
PCI stratum (n=1605)
Insulin Sensitization
Rev(n=396) 12.1% (45) 1.18 (0.77–1.80) 0.45 5.0% (23) 1.74 (0.89–3.38) 0.10 15.7% (61) 1.39 (0.95–2.03) 0.09
IMT(n=408) 11.7% (41) 3.7% (14) 13.3% (47)
Insulin Provision
Rev(n= 402) 12.4% (50) 1.08 (0.73–1.62) 0.69 5.0% (21) 1.12 (0.60–2.07) 0.73 16.3% (65) 1.23 (0.86–1.76) 0.26
IMT(n=399) 13.5% (47) 4.8% (19) 15.2% (54)
CABG stratum (n =763)
Insulin Sensitization
Rev(n=188) 6.3% (11) 0.32 (0.16–0.64) 0.001** 6.6% (11) 0.62 (0.29–1.32) 0.21 11.0% (18) 0.41 (0.24–0.72) 0.002**
IMT(n=191) 19.0% (33) 10.5% (18) 24.6%(42)
Insulin Provision
Rev(n= 190) 13.5% (22) 0.79 (0.45–1.37) 0.40 9.4% (17) 1.37 (0.67–2.83) 0.39 20.5% (34) 1.03 (0.64–1.64) 0.91
IMT(n=194) 16.2% (30) 7.6% (13) 19.3% (36)

CABG = coronary artery bypass grafting; MI = myocardial infarction; PCI = percutaneous coronary intervention; Rev/Med = revascularization/medicine;

Kaplan-Meier values are expressed as percentage (n). CI indicates confidence interal.

**

significant after Bonferroni adjustment for multiple tests done in the table